BRK-B vs IVZ
By Alex · Tickerpine
Berkshire Hathaway Inc. vs Invesco Ltd., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | BRK-B | IVZ |
|---|---|---|
| Price | $592.94 | $28.92 |
| Market cap | $1.26T | $12.71B |
| P/E ratio | 16.6 | — |
| ROE | 10.57% | -0.58% |
| Profit margin | 19.50% | -1.10% |
| Revenue growth | 11.20% | 14.20% |
| Dividend yield | 0.00% | 2.97% |
| Beta | 0.57 | 1.65 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
BRK-B vs IVZ in plain English
- BRK-B is the bigger company — about 99.1× the market cap of IVZ.
- BRK-B earns a higher return on equity (11% vs -1%).
- IVZ is growing revenue faster (14% vs 11%).
- IVZ pays a dividend (2.97%) while the other effectively doesn't.
How would $1,000 have done in each?
BRK-B return calculator
See what $1,000 in Berkshire Hathaway Inc. would be worth today.
IVZ return calculator
See what $1,000 in Invesco Ltd. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.